Tapaday 100 mg contains tapentadol, a centrally acting opioid analgesic used for the treatment of moderate to severe acute pain. Tapentadol is also marketed under the brand Nucynta. It is known for its dual mechanism of action—µ-opioid receptor agonism and norepinephrine reuptake inhibition—providing effective pain relief by modulating central pain pathways.
Tapaday 100 mg is generally prescribed when non-opioid pain relievers are inadequate. The dosage should be individualized based on pain intensity, patient response, and prior opioid exposure. It is typically taken every 4–6 hours as directed by a healthcare professional.
Common side effects include nausea, dizziness, constipation, headache, and drowsiness. Due to potential risks such as dependence, misuse, and respiratory depression, Tapaday 100 mg should be used strictly under medical supervision with appropriate monitoring for safe and responsible pain management.
